1. Home
  2. KNSA vs POWI Comparison

KNSA vs POWI Comparison

Compare KNSA & POWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • POWI
  • Stock Information
  • Founded
  • KNSA 2015
  • POWI 1988
  • Country
  • KNSA United Kingdom
  • POWI United States
  • Employees
  • KNSA N/A
  • POWI N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • POWI Semiconductors
  • Sector
  • KNSA Health Care
  • POWI Technology
  • Exchange
  • KNSA Nasdaq
  • POWI Nasdaq
  • Market Cap
  • KNSA 2.6B
  • POWI 2.3B
  • IPO Year
  • KNSA 2018
  • POWI 1997
  • Fundamental
  • Price
  • KNSA $38.01
  • POWI $42.69
  • Analyst Decision
  • KNSA Strong Buy
  • POWI Strong Buy
  • Analyst Count
  • KNSA 7
  • POWI 3
  • Target Price
  • KNSA $46.86
  • POWI $61.67
  • AVG Volume (30 Days)
  • KNSA 454.2K
  • POWI 1.7M
  • Earning Date
  • KNSA 10-28-2025
  • POWI 11-05-2025
  • Dividend Yield
  • KNSA N/A
  • POWI 1.97%
  • EPS Growth
  • KNSA N/A
  • POWI N/A
  • EPS
  • KNSA 0.47
  • POWI 0.59
  • Revenue
  • KNSA $597,973,000.00
  • POWI $442,468,000.00
  • Revenue This Year
  • KNSA $53.93
  • POWI $11.06
  • Revenue Next Year
  • KNSA $25.06
  • POWI $14.36
  • P/E Ratio
  • KNSA $84.46
  • POWI $72.23
  • Revenue Growth
  • KNSA 55.68
  • POWI 7.16
  • 52 Week Low
  • KNSA $17.82
  • POWI $34.55
  • 52 Week High
  • KNSA $42.05
  • POWI $69.53
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 50.20
  • POWI 48.91
  • Support Level
  • KNSA $35.53
  • POWI $41.75
  • Resistance Level
  • KNSA $41.28
  • POWI $45.00
  • Average True Range (ATR)
  • KNSA 1.50
  • POWI 2.47
  • MACD
  • KNSA -0.14
  • POWI 0.07
  • Stochastic Oscillator
  • KNSA 43.13
  • POWI 51.32

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About POWI Power Integrations Inc.

Power Integrations Inc designs, develops, and markets analog and mixed-signal integrated circuits (ICs) and other electronic components and circuitry used in high-voltage power conversion. Products are used in power converters that convert electricity from a high-voltage source to the type of power required for a specified downstream use. Products are used in electronic products including mobile phones, computing and networking equipment, appliances, electronic utility meters, battery-powered tools, industrial controls, home automation, or Internet of Things applications such as networked thermostats, power strips, and security devices. Geographically, the company generates maximum revenue from China and Hong Kong.

Share on Social Networks: